Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Other Operating Expenses (2021 - 2025)

Cardio Diagnostics Holdings' Other Operating Expenses history spans 5 years, with the latest figure at -$89458.0 for Q2 2025.

  • For Q2 2025, Other Operating Expenses fell 1128.82% year-over-year to -$89458.0; the TTM value through Sep 2025 reached $223351.0, up 594.91%, while the annual FY2024 figure was $202184.0, 13.78% up from the prior year.
  • Other Operating Expenses for Q2 2025 was -$89458.0 at Cardio Diagnostics Holdings, down from $87258.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $225551.0 in Q4 2024 and bottomed at -$1.0 million in Q3 2022.
  • The 5-year median for Other Operating Expenses is $20887.0 (2021), against an average of -$41740.4.
  • The largest annual shift saw Other Operating Expenses tumbled 140906.52% in 2022 before it skyrocketed 369.02% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $20887.0 in 2021, then skyrocketed by 49.03% to $31127.0 in 2022, then surged by 54.5% to $48090.0 in 2023, then surged by 369.02% to $225551.0 in 2024, then crashed by 139.66% to -$89458.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Other Operating Expenses are -$89458.0 (Q2 2025), $87258.0 (Q1 2025), and $225551.0 (Q4 2024).